In Colorado, there are over 30,000 men living with Alzheimer’s disease, a lot of them fathers, who will be the center of ...

AR1001 is a novel, disease-modifying, once-daily oral phosphodiesterase-5 (PDE5) inhibitor currently being studied in a global Phase 3 clinical trial (POLARIS-AD) for the treatment of early-stage ...

A new blood test for Alzheimer’s disease can accurately detect people with early symptoms, research suggests.Experts from the Mayo Clinic in the US have provided further evidence that blood tests can ...

In one of the largest and most comprehensive studies of its kind, a research team led at UC San Francisco has identified the ...

Changes in specific bacteria in the mouth and gut of patients with Parkinson’s disease could potentially be an early warning sign that symptoms of the condition are getting worse, a study ...

More than 30,000 men living with Alzheimer’s disease in Colorado, many of them fathers, will be the focus of attention on Sunday, June 15, as families celebrate Father’s Day. Family dynamics can ...